Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | ||
By: PR Newswire Association LLC. - 21 Sep 2017 | Back to overview list |
|
SOUTH PLAINFIELD, N.J., Sept. 21, 2017 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on September 18, 2017 it approved non-statutory stock options to purchase an aggregate of 32,500 shares of its common stock to thirteen new employees. The awards were made pursuant to the NASDAQ inducement grant exception as a component of the new hires' employment compensation. The inducement grants were approved by PTC's Compensation Committee on September 18, 2017 and are being made as an inducement material to each employee's acceptance of employment with the Company in accordance with NASDAQ Listing Rule 5635(c)(4). Eleven of the stock option awards have an exercise price of $20.41 per share, the closing price of PTC's common stock on September 18, 2017, the date of the grant. The two remaining stock option awards will have an exercise price equal to the closing stock price of PTC's common stock on the applicable employees' new hire date, or the first trading day thereafter, which will be the date of grant. The stock options each have a 10-year term and vest over four years, with 25% of the original number of shares vesting on the first anniversary of the applicable employee's new hire date and an additional 6.25% of the original number of shares vesting at the end of each subsequent three-month period thereafter, subject to the employee's continued service with the Company through the applicable vesting dates. ABOUT PTC THERAPEUTICS, INC. For More Information: Investors: Media: View original content:http://www.prnewswire.com/news-releases/ptc-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-300524019.html SOURCE PTC Therapeutics, Inc. |
||
|
||
Copyright 2017 PR Newswire Association LLC. | Back to overview list |